Mediwhale's Dr. Noon CVD: Pioneering Cardiovascular Risk Assessment with AI On November 18, 2024, Mediwhale, a South Korean medical AI leader, marked a milestone by concluding its third pre-submission meeting with the FDA regarding Dr. Noon CVD, an innovative retinal scan too...

www.linkedin.com/pulse/mediwh...

Mediwhale's Dr. Noon CVD: Pioneering Cardiovascular Risk Assessment with AI

kstrategyand.com/digital-heal...

#Mediwhale #AIHealthcare #HeartHealth #MetabolicSyndrome #HispanicHealth #ClinicalTrials #HealthTech #Humanteconomy #Humantec #KStrategyand

#Mediwhale, the AI-powered health diagnostics company, announced $12 million series A2 investments. #ai